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Determination of the effect of fluconazole against Candida
albicans and Candida glabrata by using microbroth kinetic assay*
Esma KAYA, Hatice ÖZBİLGE

Aim: To evaluate the antifungal activity of a model antifungal (fluconazole) against Candida albicans (ATCC 90028) and
Candida glabrata (RSKK 04019) strains using a microbroth kinetic assay based on continuous monitoring of changes in
the optical density of fungal growth. Recently, antifungal susceptibility testing has become more important because of
the increasing incidence of both fungal infections and antifungal drug resistance.
Materials and methods: The optical growth densities of C. albicans and C. glabrata in the presence of increasing
concentrations of fluconazole were measured every 15 min for 24 h at 35 °C, using a multidetection microplate reader
at 405 nm. The turbidimetric growth curves of these strains were obtained, and the minimal inhibitory concentration
(MIC) values for fluconazole were determined with this kinetic assay. Furthermore, the conventional broth microdilution
method was performed according to Clinical and Laboratory Standards Institute reference method M27-A2.
Results: MIC90 values for fluconazole were determined as 0.31 μg/mL for C. albicans and 16.32 μg/mL for C. glabrata.
Conclusion: Using kinetic procedures, the effects of antifungal drugs on target yeasts can be determined at any desired
time-point of the incubation period.
Key words: Candida, fluconazole, minimal inhibitory concentration, growth curve, optical density, kinetic assay

Candida albicans ve Candida glabrata’ya karşı flukonazolün etkisinin
belirlenmesinde mikrobroth kinetik yöntemin kullanılması
Amaç: Bu çalışmada, Candida albicans (ATCC 90028) ve Candida glabrata (RSKK 04019) suşlarının model antifungal
olarak seçilen flukonazole karşı antifungal aktivitesi, fungal üremedeki optik dansite değişikliklerini sürekli olarak
izlemeye olanak veren kinetik bir sistemle belirlenmiştir. Antifungal duyarlılık testleri son yıllarda gerek fungal
enfeksiyonlardaki artış gerekse artan antifungal ilaç direnci nedeniyle giderek daha önemli hale gelmiştir.
Yöntem ve gereç: C. albicans ve C. glabrata’nın flukonazolün artan konsantrasyonları varlığında, multi-detection
microplate okuyucu kullanılarak 405 nm’de 35 °C’de 24 saat süreyle her 15 dakikada bir optik dansiteleri ölçüldü. Bu
kinetik sistemle suşların turbidimetrik üreme eğrileri elde edildi ve flukonazolün minimal inhibitör konsantrasyon
(MİK) değerleri belirlendi. Ayrıca CLSI referans yöntem M27-A2’ye göre konvansiyonel sıvı mikrodilüsyon yöntemi
uygulandı.
Bulgular: Flukonazol MİK90 değerleri C. albicans için 0,31 μg/mL; C. glabrata için 16,32 μg/mL olarak belirlendi.
Sonuç: Kinetik ölçüm yapan yöntemler kullanılarak antifungal ilaçların mayalar üzerindeki etkileri inkübasyon
süresince istenilen herhangi bir zamanda gözlenebilir.
Anahtar sözcükler: Candida, flukonazol, minimal inhibitör konsantrasyon, üreme eğrisi, optik dansite, kinetik yöntem
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Use of kinetic assay for antifungal activity

Introduction
Recently, antifungal susceptibility testing has become
more important because of the increasing incidence
of both fungal infections and antifungal drug
resistance (1,2). For this reason, the Clinical and
Laboratory Standards Institute (CLSI) has developed
a reference method for broth dilution antifungal
susceptibility testing of yeasts (3). This CLSI
document recommends the visual determination
of 48-h minimum inhibitory concentration (MIC)
values, with the azole MIC being defined as the
lowest concentration at which a prominent decrease
in turbidity is observed (4,5). However, a visual
evaluation of the results is partly a subjective
assessment, and it has been seen that the trailing
effect of azoles complicates the determination of their
MIC values (2,5,6). It has been demonstrated that
this decrease in growth (turbidity), as determined by
a spectrophotometer, corresponds to approximately
50% inhibition in growth (4,5).
The turbidimetric growth curves of yeasts and
molds in the presence of antifungal agents can be
obtained by using a spectrophotometric kinetic assay
based on continuous monitoring of changes in the
optical density (OD) of fungal growth (7,8). Using
this assay, the MIC values of drugs can be determined
in a shorter period than with conventional methods.
Results can also be detected during exposure and are
more objective because spectrophotometric MICs
are determined instead of visual MICs. Thus, using
kinetic procedures, the effects of antifungal drugs on
target yeasts can be determined at any desired timepoint of the incubation period (7-9). In this study,
we aimed both to describe the turbidimetric growth
curves of Candida albicans and Candida glabrata in
the presence of increasing concentrations of a model
antifungal (fluconazole) and to determine the MIC
by using this system.
Materials and methods
Strains and preparation of inocula: C. albicans
(American Type Culture Collection (ATCC) 90028)
and C. glabrata (Refik Saydam Culture Collection
(RSKK) 04019) strains were used in this study. The
strains were inoculated onto Sabouraud dextrose
agar (Acumedia, USA) plates from glycerol stocks
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and incubated at 35 °C for 24 h. They were then
subcultured on the same medium for a further 24 h
at 35 °C. The yeast inocula were prepared by diluting
the overnight culture with 0.9% NaCl to 1-5 × 106
CFU/mL compared to the isolate density standard
(Phoenix Spec Nephelometer, Becton Dickinson,
USA). The yeast suspensions were then further
diluted in RPMI-1640 (with L-glutamine, without
sodium bicarbonate) (Sigma, USA) supplemented
with 0.165 M morpholinepropanesulfonic acid
(MOPS) to a final inoculum ranging between 0.5 ×
103 and 2.5 × 103 CFU/mL.
Antifungal agent: The antifungal agent
fluconazole (Mustafa Nevzat, Turkey) was dissolved
in distilled water at a final concentration of 2560
mg/L. Ten 2-fold serial dilutions were prepared in
RPMI-1640 medium, with final drug concentrations
ranging from 64 to 0.125 μg/mL of fluconazole,
according to CLSI M27-A2 (3).
Susceptibility testing: Fluconazole MICs were
determined using the broth microdilution method
described in CLSI M27-A2 for yeasts.
Growth curves: Fungal inocula (100 μL) were
added to each well of a sterile, 96-well flat-bottomed
microtiter plate containing the test concentration
of fluconazole (100 μL/well). Each concentration
was tested in duplicate for each organism. Two
wells containing fungal suspension with no drug
(growth control) and 2 wells containing only
media (background control) were included in this
plate. ODs were measured for 24 h at 35 °C using a
multidetection microplate reader (Bio-Tek-Synergy
HT microplate reader, Bio-Tek Instruments, USA)
at 405 nm and were automatically recorded every
15 min for each well. Turbidimetric growth curves
were obtained depending on the changes in the OD
of fungal growth for each drug concentration and the
drug-free growth control.
In order to determine fluconazole MICs using
the spectrophotometric kinetic assay, the growth
percentage for each drug concentration was calculated
with the following equation: growth % = [(OD405
of wells containing the drug/OD405 of the drug-free
well) × 100] after the subtraction of background ODs
(ODs of microorganism-free wells).
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Using Microplate Data Collection and Analysis
Software (Bio-Tek Instruments), the highest OD
(ODmax), time at mean maximum OD, changes in
ODs (delta OD = ODfinal – ODinitial) for each well,
and inhibition percentage values were calculated.
MIC curves and MIC curve interpolations for each
organism were obtained using these values.

Table. MIC curves interpolations of fluconazole against C.
albicans and C. glabrata.
Concentrations of fluconazole (μg/mL)
Inhibition %

Using the microbroth kinetic assay, MIC90 values
of fluconazole were determined as 0.31 μg/mL for
C. albicans and 16.32 μg/mL for C. glabrata in the
first 20 h of the incubation period. Using the broth
microdilution method, fluconazole MICs were
determined as 0.5 μg/mL for C. albicans and 8 μg/mL
for C. glabrata at 48 h.
MIC curves and MIC curve interpolations for
each strain are given in Figures 1 and 2 and the Table,
respectively.
Discussion
Early appropriate therapy may alter the course of
fungal infections especially, in immunodeficient
or immunosuppressed patients. Therefore, early
determination of an organism’s drug susceptibility
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Ostrosky-Zeichner et al. (11) investigated the
correlation of 48- and 24-h fluconazole MICs in
505 Candida isolates according to the CLSI M27-A2
method, and they showed good correlation between
48- and 24-h visual MICs. Furthermore, EspinelIngroff et al. (4) compared the performance of 24-h
visual and 48-h spectrophotometric MIC endpoints
to reference the 48-h microdilution broth visual
MICs (CLSI M27-A2 document) of fluconazole,
itraconazole, voriconazole, and posaconazole for
Candida spp. They reported that the performance
of both investigational MIC endpoint readings gave
results similar to those of reference MICs. They
emphasized that spectrophotometric MICs are more
objective than visual MICs.
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may contribute to successful treatment (1,10).
Researchers have performed a number of studies on
antifungal susceptibility testing in order to provide
clinicians with useful susceptibility information
sooner (4,8,11).
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Results
The growth curves of C. albicans and C. glabrata
during the incubation period in the presence of
increasing concentrations of fluconazole were
obtained. The growth curves of both strains in
each well were monitored every minute from the
beginning of the incubation period. With the increase
of the fluconazole concentration inside the wells, an
inhibition was observed in the growth curves.
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Figure 1. MIC curve of fluconazole against C. albicans (Y,
inhibition %; X, concentrations of fluconazole).

Figure 2. MIC curve of fluconazole against C. glabrata (Y,
inhibition %; X, concentrations of fluconazole).
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In this study, a microbroth kinetic system, which
provides kinetic data throughout the incubation
period, was used to determine antifungal activity. We
were able to observe the effects of fluconazole on both
strains by examining turbidimetric growth curves
at any desired time-point. We measured the ODs
of fungal growth kinetically in each well at selected
time intervals and calculated the MICs of the drug
using delta ODs in a shorter time than the reference
method (approximately 16-20 h) in this assay.
Kinetic measurements of microorganism
susceptibilities to antimicrobial agents can also be
performed by bioluminescence-, fluorescence-, and
OD-based real-time assay using a multidetection
microplate reader (9,12). There are only a limited
number of studies using this method on fungi,
especially yeasts. Balajee et al. (12) used fluorescencebased a microplate assay to determine the antifungal
drug susceptibility of Aspergillus species. They were
able to calculate the MICs of various antifungal
drugs against conidia in 16 h with this method by
measuring the fluorescence using a viability dye.
They found that their results correlated with the

reference microdilution method. Meletiadis et al. (8)
showed that the antifungal drug resistance of various
filamentous fungi could be determined earlier using
a microbroth kinetic system based on continuous
monitoring of OD fungal growth over a period of
time. They determined itraconazole, terbinafine,
and amphotericin B resistance using this system in
incubation periods of 5.0 to 7.7 h for Rhizopus oryzae,
8.8 to 11.4 h for Aspergillus fumigatus, 6.7 to 8.5 h for
Aspergillus flavus, and 13 to 15.6 h for Scedosporium
prolificans while awaiting formal MIC determination
by the CLSI reference method at 24-48 h.
Using kinetic measurements, fungi growth
characteristics can be monitored even in the time
interval from exposure to visible effect for antifungal
agents in real-time. Hence, the effects of antifungals
on a target fungus can be observed at any desired
time-point of the incubation period, and they may
thus be useful for the detection of in vitro antifungal
resistance at an earlier stage. The results can also be
detected during exposure and are more objective
because the MICs can be determined kinetically
through spectrophotometric analysis (7,8,12).
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